Scarica l'app Stockscreener
4.03
0.50%
0.02
Dopo l'orario di chiusura:
4.02
-0.01
-0.25%
Precedente Chiudi:
$4.01
Aprire:
$4.1
Volume 24 ore:
2,340
Relative Volume:
0.17
Capitalizzazione di mercato:
$46.16M
Reddito:
$10.96M
Utile/perdita netta:
$-7.02M
Rapporto P/E:
-6.2969
EPS:
-0.64
Flusso di cassa netto:
$-3.72M
1 W Prestazione:
-4.01%
1M Prestazione:
+10.71%
6M Prestazione:
-20.04%
1 anno Prestazione:
-24.39%
Intervallo 1D:
$4.00
$4.15
Intervallo di 1 settimana:
$3.79
$4.31
Portata 52W:
$3.24
$6.75
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Nome
Collplant Biotechnologies Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta CLGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
4.03 | 46.16M | 10.96M | -7.02M | -3.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-02-17 | Iniziato | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Borsa (CLGN) Ultime notizie
Contrasting CollPlant Biotechnologies (NASDAQ:CLGN) and Pathfinder Cell Therapy (OTCMKTS:PFND) - Defense World
Collplant stock hits 52-week low at $3.24 amid market challenges By Investing.com - Investing.com South Africa
Collplant stock hits 52-week low at $3.24 amid market challenges - Investing.com India
CLGN (CollPlant Biotechnologies) 50-Day SMA : $4.31 (As of Dec. 01, 2024) - GuruFocus.com
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q3 2024 Earnings Call Transcript - MSN
CLGNCollPlant Biotechnologies Ltd Ordinary Shares Latest Stock News & Market Updates - StockTitan
CollPlant Biotechnologies Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Highlights: Navigating Revenue ... By GuruFocus - Investing.com Canada
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Highl - GuruFocus.com
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Highlights: Navigating Revenue ... - Yahoo Finance
CollPlant Biotechnologies’ Q3 2024 Financial Update - TipRanks
Q3 2024 Collplant Biotechnologies Ltd Earnings Call Transcript - GuruFocus.com
CollPlant Issues Letter to Shareholders - GuruFocus.com
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PR Newswire
What To Expect From CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings - GuruFocus.com
Collplant stock hits 52-week low at $3.56 amid market challenges - Investing.com Canada
Collplant stock hits 52-week low at $3.56 amid market challenges By Investing.com - Investing.com South Africa
CollPlant Biotechnologies (CLGN) Set to Announce Earnings on Wednesday - Defense World
CollPlant (CLGN) to Report Q3 2024 Earnings on Nov 27: Conference Call Details | CLGN Stock News - StockTitan
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION – Company AnnouncementFT.com - Financial Times
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - PR Newswire
Companies Like CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Invest In Growth - Yahoo Finance
Collplant stock hits 52-week low at $3.61 amid market challenges - Investing.com Australia
500: Something went wrong - Investing.com India
Collplant stock hits 52-week low at $3.75 amid market challenges - Investing.com Australia
EF Hutton Initiates Coverage of CollPlant Biotechnologies (CLGN) with Buy Recommendation - MSN
Collplant stock hits 52-week low at $4.05 amid market challenges - Investing.com India
Collplant stock hits 52-week low at $4.05 amid market challenges By Investing.com - Investing.com South Africa
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Update - Defense World
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Up 5.3% in September - MarketBeat
Benjamin F. Edwards & Company Inc. Sells 10,690 Shares of CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) - Defense World
CollPlant Shareholders Approve Key Proposals - TipRanks
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Growth in Short Interest - MarketBeat
3D Bioprinting Market valued at USD 1.41 billion in 2024 | ExactitudeConsultancy - GlobeNewswire
CollPlant (CLGN), Stratasys Initiate Study for Breast Implants - MSN
CollPlant and Stratasys Launch Pre-clinical Trial for Regenerative 3D-Printed Breast Implants - 3DPrint.com
The Stratasys’ Origin® printer to be tested for CollPlant’s 3D-printed breast implants - 3d adept media
HC Wainwright Weighs in on CollPlant Biotechnologies Ltd.'s Q3 2024 Earnings (NASDAQ:CLGN) - MarketBeat
Head-To-Head Analysis: Envoy Medical (NASDAQ:COCH) and CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World
HC Wainwright Weighs in on CollPlant Biotechnologies Ltd.’s Q3 2024 Earnings (NASDAQ:CLGN) - Defense World
FY2027 EPS Estimates for CollPlant Biotechnologies Ltd. Reduced by HC Wainwright (NASDAQ:CLGN) - MarketBeat
HC Wainwright Research Analysts Cut Earnings Estimates for CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) - Defense World
Global Tooth Regeneration Market Size To Worth USD 8.20 Billion By 2033 | CAGR Of 6.18% - GlobeNewswire Inc.
CollPlant Schedules Shareholder Meeting - Investing.com India
CollPlant Schedules Shareholder Meeting By Investing.com - Investing.com Australia
Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies - Benzinga
CollPlant Biotechnologies’ (CLGN) Buy Rating Reaffirmed at HC Wainwright - Defense World
Collplant Biotechnologies Ltd Azioni (CLGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.65%
4.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):